1-4 of 4
Yonghong Shi
Close
Sort by
Journal Articles

High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cells

Sina Oppermann, Jarkko Ylanko, Yonghong Shi, Santosh Hariharan, Christopher C. Oakes, Patrick M. Brauer, Juan C. Zúñiga-Pflücker, Brian Leber, David E. Spaner, David W. Andrews
Journal: Blood
Blood (2016) 128 (7): 934–947.
https://doi.org/10.1182/blood-2015-12-687814
Published: 2016
Includes: Supplemental data
Journal Articles

Microenvironmental interleukin-6 suppresses toll-like receptor signaling in human leukemia cells through miR-17/19A

Yanmei Li, Yonghong Shi, Lindsay McCaw, You-Jun Li, Fang Zhu, Reg Gorczynski, Gordon S. Duncan, Burton Yang, Yaacov Ben-David, David E. Spaner
Journal: Blood
Blood (2015) 126 (6): 766–778.
https://doi.org/10.1182/blood-2014-12-618678
Published: 2015
Includes: Supplemental data
Journal Articles

PPARα and fatty acid oxidation mediate glucocorticoid resistance in chronic lymphocytic leukemia

Stephanie Tung, Yonghong Shi, Karry Wong, Fang Zhu, Reg Gorczynski, Robert C. Laister, Mark Minden, Anne-Kareen Blechert, Yvonne Genzel, Udo Reichl, David E. Spaner
Journal: Blood
Blood (2013) 122 (6): 969–980.
https://doi.org/10.1182/blood-2013-03-489468
Published: 2013
Includes: Supplemental data
Journal Articles

Extracellular calcium sensing promotes human B-cell activation and function

Caitlin M. Hammond, Dionne White, Jelena Tomic, Yonghong Shi, David E. Spaner
Journal: Blood
Blood (2007) 110 (12): 3985–3995.
https://doi.org/10.1182/blood-2007-05-088468
Published: 2007